Schedule 13G ownership disclosure

COGENT BIOSCIENCES INC

Security class unavailable · CUSIP: 19240Q201

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
115,166,672
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-119314
Form type
SC 13G
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub